These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9174001

  • 1. Co-expression of beta-amyloid precursor protein (betaAPP) and apolipoprotein E in cell culture: analysis of betaAPP processing.
    Biere AL, Ostaszewski B, Zhao H, Gillespie S, Younkin SG, Selkoe DJ.
    Neurobiol Dis; 1995 Jun; 2(3):177-87. PubMed ID: 9174001
    [Abstract] [Full Text] [Related]

  • 2. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S, Abraham CR, Zannis VI.
    Biochemistry; 1997 Aug 26; 36(34):10571-80. PubMed ID: 9265639
    [Abstract] [Full Text] [Related]

  • 3. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein.
    Irizarry MC, Deng A, Lleo A, Berezovska O, Von Arnim CA, Martin-Rehrmann M, Manelli A, LaDu MJ, Hyman BT, Rebeck GW.
    J Neurochem; 2004 Sep 26; 90(5):1132-43. PubMed ID: 15312168
    [Abstract] [Full Text] [Related]

  • 4. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
    Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM, Paul SM.
    Proc Natl Acad Sci U S A; 2005 Jan 25; 102(4):1211-6. PubMed ID: 15657137
    [Abstract] [Full Text] [Related]

  • 5. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
    Dolev I, Michaelson DM.
    Proc Natl Acad Sci U S A; 2004 Sep 21; 101(38):13909-14. PubMed ID: 15365176
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR, Capetillo-Zarate E, Schultz C, Rüb U, Saido TC, Yamaguchi H, Haass C, Griffin WS, Del Tredici K, Braak H, Ghebremedhin E.
    Acta Neuropathol; 2005 Nov 21; 110(5):459-71. PubMed ID: 16195918
    [Abstract] [Full Text] [Related]

  • 7. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J, Walker LC, Schroeder E, Vogelgesang S, Stausske D, Walther R, Warzok RW.
    Acta Neuropathol; 2003 Jan 21; 105(1):25-9. PubMed ID: 12471457
    [Abstract] [Full Text] [Related]

  • 8. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.
    Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM.
    Neurobiol Dis; 2002 Apr 21; 9(3):305-18. PubMed ID: 11950276
    [Abstract] [Full Text] [Related]

  • 9. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM, Thorngate FE, Katoh-Fukui Y, Hamanaka H, Williams DL, Fujita S, Lamb BT.
    Hum Mol Genet; 2004 Sep 01; 13(17):1959-68. PubMed ID: 15229191
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L, Chen L, Ng HK, Pang CP.
    Microsc Res Tech; 2000 Aug 15; 50(4):278-81. PubMed ID: 10936880
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT.
    Ann Neurol; 2000 Jun 15; 47(6):739-47. PubMed ID: 10852539
    [Abstract] [Full Text] [Related]

  • 12. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR, Larionov S, Abramowski D, Wiederhold KH, Van Dooren T, Yamaguchi H, Haass C, Van Leuven F, Staufenbiel M, Capetillo-Zarate E.
    Neurobiol Aging; 2007 Aug 15; 28(8):1221-30. PubMed ID: 16815595
    [Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.
    Biol Psychiatry; 2004 Nov 01; 56(9):670-6. PubMed ID: 15522251
    [Abstract] [Full Text] [Related]

  • 14. Identification of a unique apolipoprotein E allele in Microcebus murinus; ApoE brain distribution and co-localization with beta-amyloid and tau proteins.
    Calenda A, Jallageas V, Silhol S, Bellis M, Bons N.
    Neurobiol Dis; 1995 Jun 01; 2(3):169-76. PubMed ID: 9174000
    [Abstract] [Full Text] [Related]

  • 15. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid.
    Yamauchi K, Tozuka M, Nakabayashi T, Sugano M, Hidaka H, Kondo Y, Katsuyama T.
    J Neurosci Res; 1999 Oct 15; 58(2):301-7. PubMed ID: 10502286
    [Abstract] [Full Text] [Related]

  • 16. The effects of AbetaPP mutations and APOE polymorphisms on cerebral amyloid angiopathy.
    Rebeck GW, Cho HS, Grabowski TJ, Greenberg SM.
    Amyloid; 2001 Jul 15; 8 Suppl 1():43-7. PubMed ID: 11676289
    [Abstract] [Full Text] [Related]

  • 17. Isoform-specific interactions of human apolipoprotein E to an intermediate conformation of human Alzheimer amyloid-beta peptide.
    Stratman NC, Castle CK, Taylor BM, Epps DE, Melchior GW, Carter DB.
    Chem Phys Lipids; 2005 Oct 15; 137(1-2):52-61. PubMed ID: 16140289
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease.
    Donahue JE, Johanson CE.
    J Neuropathol Exp Neurol; 2008 Apr 15; 67(4):261-70. PubMed ID: 18379441
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease.
    Lahiri DK, Sambamurti K, Bennett DA.
    Neurobiol Aging; 2004 Apr 15; 25(5):651-60. PubMed ID: 15172744
    [Abstract] [Full Text] [Related]

  • 20. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W, Zhang J, Ostaszewski BL, Kimberly WT, Seubert P, Koo EH, Shen J, Selkoe DJ.
    Biochemistry; 1998 Nov 24; 37(47):16465-71. PubMed ID: 9843412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.